Summary
Although plasma insulin and triglyceride concentrations are positively correlated in many studies, the relationships between insulin resistance, insulin secretion and hypertriglyceridaemia remain unclear. To study these associations, subjects between the ages of 40 and 64 were randomly selected from a general practice register and invited to attend for a standard oral glucose tolerance test for measurement of insulin, triglyceride and non-esterified fatty acid concentrations. The study comprised 1122 subjects who were not previously known to have diabetes and who completed the test. Using the World Health Organisation criteria, 51 subjects were classified to have non-insulin-dependent diabetes mellitus, 188 had impaired glucose tolerance and 883 subjects had normal glucose tolerance. Triglyceride concentrations in subjects with glucose intolerance were elevated compared to those in control subjects, even after adjustment for age, obesity and gender (p<0.001 for subjects with diabetes and p<0.01 for those with impaired glucose tolerance compared to normal subjects). In separate multiple regression analyses for males and females, the most important determinants of the plasma triglyceride concentration were the area under the non-esterified fatty acid suppression curve (p<0.001 in both genders) and the waist-hip ratio (p<0.001 for men and <0.01 for women). The fasting insulin concentration was independently associated with triglyceride concentration in women only (p<0.01). The most important determinant of the area under the non-esterified fatty acid suppression curve in men was the 30-min insulin increment, a measure of insulin secretion, (p<0.001) whereas for women age (p<0.001) and the body mass index (p<0.01) were the most important.
Article PDF
Similar content being viewed by others
Abbreviations
- NIDDM:
-
non-insulin-dependent diabetes mellitus
- IGT:
-
impaired glucose tolerance
- NEFA:
-
non-esterified fatty acid
References
Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. J Am Med Soc 241: 2035–2038
Assman G, Schultz H (1988) The prospective cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 116: 1713–1724
Uusitupa M, Siitonen O, Aro A, Pyörälä K (1985) Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 28: 22–27
Stern MP, Haffner SM (1991) Dyslipidemia in type II diabetes. Diabetes Care 14: 1144–1159
Dunn FL (1990) Hyperlipidaemia in diabetes mellitus. Diabetes Metab Rev 6: 47–61
Gotto AM (1992) Hypertriglyceridemia: risks and perspectives. Am J Cardiol 70: 19H-25H
Reaven GM (1988) The role of insulin resistance in human disease. Diabetes 37: 1595–1607
Williams DRR, Byrne C, Clark PMS et al. (1991) Raised proinsulin as early indicator of β cell failure. BMJ 303: 95–96
Davies MJ, Rayman G, Gray IP, Day IL, Hales CN (1993) Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 10: 313–320
Lillioja S, Mott DM, Howard BV et al. (1988) Impaired glucose tolerance as a disorder of insulin action. N Engl J Med 318: 1217–1225
Temple RC, Carrington CA, Luzio SD et al (1989) Insulin deficiency in non-insulin dependent diabetes. Lancet I: 293–295
Banerji MA, Lebovitz HE (1989) Insulin sensitive and insulin resistant variants in NIDDM. Diabetes 38: 784–792
Davies MJ, Metcalfe IP, Gray JL, Day JL, Hales CN (1993) Insulin deficiency rather than hyperinsulinaemia in newly diagnosed diabetes mellitus. Diabet Med 10: 305–312
Durrington PN, Newton S, Weinstein DB, Steinberg D (1982) Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest 70: 63–73
Pullinger CR, North JD, Teng BB, Rifici VA, Ronhild de Brito AE, Scott J (1989) The apolipoprotein gene is constitutively expressed in Hep G2 cells: regulation of secretion by oleic acid, albumin and insulin, and measurement of mRNA half life. J Lipid Res 30: 1065–1077
Byrne CD, Brindle NPJ, Wang TWM, Hales CN (1991) Interaction of non esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells. Biochem J 280: 99–104
Byrne CD, Wang TWM, Hales CN (1992) Control of Hep G2 cell triacylglycerol and apolipoprotein-B synthesis and secretion by polyunsaturated non esterified fatty acids and insulin. Biochem J 288: 101–107
Reaven GM, Chen YD (1988) Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 4: 639–652
Kissebah AH, Alfarsi S, Evans DJ, Adams PW (1982) Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin dependent diabetes mellitus. Diabetes 31: 217–225
Abrams JJ, Ginsberg H, Grundy SM (1982) Metabolism of cholesterol and triglycerides in non-ketotic diabetes mellitus. Diabetes 31: 903–910
Ginsberg HN (1991) Lipoprotein physiology in non diabetic and diabetic states. Diabetes Care 14: 839–855
Kunst A, Draeger B, Ziegenhorn J (1983) UV-methods with hexokinase and glucose 6-phosphate dehydrogenase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, Vol VI. Weinheim Verlag Chemie, Deerfield, pp 163–172
Sobey WJ, Beer SF, Carrington CA et al. (1989) Sensitive and specific two site immunoradiometric assays for human insulin, proinsulin, 65–66 split and 32–33 split proinsulins. Biochem J 260: 535–541
Alpha B, Cox L, Crowther N, Clark PMS, Hales CN (1992) Sensitive amplified immunoenzymometric assays (IEMA) for human insulin and intact proinsulin. Eur J Clin Chem Clin Biochem 30: 27–32
Shimizu S (1980) Enzymatic determination of serum-free fatty acids: a colorimetric method. Anal Biochem 107: 193–198
WHO study group (1985) Diabetes mellitus. Technical report series No 727. WHO, Geneva
Weiland D, Mondon CE, Reaven GM (1980) Evidence for multiple causality in the development of diabetic hypertriglyceridemia. Diabetologia 18: 335–340
Yki-Jarvinen H, Taskinen M-R (1988) Interrelationships among insulin's lipolytic and glucoregulatory effects and plasma triglycerides in non-diabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes 37: 1271–1279
Coppack SW, Evans RD, Fisher RM et al. (1992) Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 41: 264–272
Kissebah AH, Adams PW, Wynn V (1974) Inter-relationships between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (phenformin). Diabetologia 10: 119–130
Cascales C, Mangiapane EH, Brindley DN (1984) Oleic acid promotes the activation and translocation of phosphatidate phosphohydrolase from the cytosol to particulate fractions of isolated rat hepatocytes. Biochem J 219: 911–916
Haagsman HP, Van Golde LMG (1981) Synthesis and secretion of very low density lipoproteins by isolated rat hepatocytes in suspension: role of diacylglycerol acyltransferase. Arch Biochem Biophys 208: 395–402
Pittner RA, Fears R, Brindley DN (1985) Effects of cyclic AMP glucocorticoids and insulin on the activities of phosphatidate phosphohydrolase, tyrosine aminotransferase and glycerol kinase in isolated rat hepatocytes in relation to the control of triacylglycerol synthesis and gluconeogenesis. Biochem J 255: 455–462
Laakso M (1993) How good a marker is insulin level for insulin resistance? Am J Epidemiol 137: 959–965
Phillips DIW, Clark PM, Hales CN, Osmond C (1994) Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11: 286–292
Reaven GM, Greenfield MS (1981) Diabetic hypertriglyceridemia: evidence for three clinical syndromes. Diabetes 30: 66–75
Tobey TA, Greenfield MS, Kraemer F, Reaven GM (1981) Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165–171
Steiner G, Haynes FJ, Yoshino G, Vranic M (1982) Hyperinsulinemia and in vivo very low density lipoprotein triglyceride kinetics. Am J Physiol 246: E187-E192
O'Brien T, Young WF, Palumbo PJ, O'Brien PC, Service FJ (1993) Hypertension and dyslipidemia in patients with insulinoma. Mayo Clin Proc 68: 141–146
Salomaa VV, Tuomilehto J, Jauhiainen M et al. (1992) Hypertriglyceridaemia in different degrees of glucose intolerance in a Finnish population-based study. Diabetes Care 15: 657–665
Eckel RH (1987) Adipose tissue lipoprotein lipase. In: Borensztajn J (ed) Lipoprotein lipase. Evener, Chicago, pp 79–132
Nikkila EA (1984) Plasma lipid and lipoprotein abnormalities in diabetes. In: Jarrett RJ (ed) Diabetes and heart disease. Elsevier, Amsterdam, pp 133–167
Eckel RH (1989) Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 320: 1060–1068
Brunzell JD, Porte D, Bierman EL (1975) Reversible abnormalities in post heparin lipolytic activity during the late phase of release in diabetes mellitus (post heparin lipolytic activity in diabetes). Metabolism 24: 1123–1137
Pykolisto OJ, Smith PH, Brunzell JD (1975) Determinants of human adipose tissue lipoprotein lipase: effect of diabetes and obesity on basal- and diet-induced activity. J Clin Invest 56: 1108–1117
Taskinen MR, Beltz WF, Harper I et al. (1986) The effect of non insulin-dependent diabetes mellitus on VLDL triglyceride and VLDL apoB metabolism: studies before and after sulphonylurea therapy. Diabetes 35: 1268–1277
Ashwell M, Cole TJ, Dixon AK (1985) Obesity: new insights into the anthropometric classification of fat distribution shown by computed tomography. BMJ 290: 1692–1694
Mårin P, Andersson B, Ottosson M et al (1992) The morphology and metabolism of intra-abdominal adipose tissue in men. Metabolism 41: 1242–1248
McKeigue PM, Laws A, Chen YD, Marmot MG, Reaven GM (1993) Relation of plasma triglyceride and apo B levels to insulin-mediated suppression of non esterified fatty acids. Arterioscler Thromb 13: 1187–1192
Kannel WB (1985) Lipids, diabetes and coronary heart disease: insights from the Framingham Study. Am Heart J 110: 1100–1107
Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL (1991) Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265: 627–631
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Byrne, C.D., Wareham, N.J., Brown, D.C. et al. Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia 37, 889–896 (1994). https://doi.org/10.1007/BF00400944
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400944